VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 28 filers reported holding VASCULAR BIOGENICS LTD in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 860,605 | $3,830,000 | 5.08% |
| TURNER INVESTMENTS LLC | 41,691 | $186,000 | 0.12% |
| MENTA CAPITAL LLC | 99,935 | $445,000 | 0.05% |
| Migdal Insurance & Financial Holdings Ltd. | 396,726 | $1,765,000 | 0.04% |
| First Eagle Investment Management, LLC | 655,574 | $2,917,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 14,680 | $65,000 | 0.01% |
| Burt Wealth Advisors | 1,674 | $7,000 | 0.01% |
| Alyeska Investment Group, L.P. | 83,333 | $371,000 | 0.00% |
| MACQUARIE GROUP LTD | 330,000 | $1,469,000 | 0.00% |
| FRANKLIN RESOURCES INC | 452,677 | $2,014,000 | 0.00% |